Jens Rasenack
Freiburg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Sex-specific effects of TLR9 promoter variants on spontaneous clearance of HCV infection.
Journal: Gut
Published: June 25, 2015
Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection.
Journal: Hepatology (Baltimore, Md.)
Published: January 06, 2015
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial.
Journal: Journal of viral hepatitis
Published: July 11, 2014
Telbivudine improves renal function in patients with chronic hepatitis B.
Journal: Gastroenterology
Published: May 31, 2013
Prediction of minimal residual viremia in HCV type 1 infected patients receiving interferon-based therapy.
Journal: Annals of hepatology
Published: February 12, 2013
Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3.
Journal: Journal of viral hepatitis
Published: August 07, 2012
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin.
Journal: Journal of viral hepatitis
Published: April 24, 2012
Importance of minimal residual viremia for relapse prediction in patients with chronic hepatitis C genotype 1 infection.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 25, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026